References
- Sethi S, Fervenza FC. Standardized classification and reporting of glomerulonephritis. Nephrol Dial Transplant 2019;34(2):193-9. https://doi.org/10.1093/ndt/gfy220
- McGrogan A, Franssen CF, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrol Dial Transplant 2011;26(2):414-30. https://doi.org/10.1093/ndt/gfq665
- Floege J, Amann K. Primary glomerulonephritides. Lancet 2016;387(10032):2036-48. https://doi.org/10.1016/S0140-6736(16)00272-5
- Chou YH, Lien YC, Hu FC, Lin WC, Kao CC, Lai CF, et al. Clinical outcomes and predictors for ESRD and mortality in primary GN. Clin J Am Soc Nephrol 2012;7(9):1401-8. https://doi.org/10.2215/CJN.04500511
- Sethi S, Haas M, Markowitz GS, D'Agati VD, Rennke HG, Jennette JC, et al. Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN. J Am Soc Nephrol 2016;27(5):1278-87. https://doi.org/10.1681/ASN.2015060612
- Radhakrishnan J, Cattran DC. The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient. Kidney Int 2012;82(8):840-56. https://doi.org/10.1038/ki.2012.280
- Jiang S, Chuang PY, Liu ZH, He JC. The primary glomerulonephritides: a systems biology approach. Nat Rev Nephrol 2013;9(9):500-12. https://doi.org/10.1038/nrneph.2013.129
- Wang YJ, He LQ, Sun W, Lu Y, Wang XQ, Zhang PQ, et al. Optimized project of traditional Chinese medicine in treating chronic kidney disease stage 3: a multicenter double-blinded randomized controlled trial. J Ethnopharmacol 2012;139(3):757-64. https://doi.org/10.1016/j.jep.2011.12.009
- Huang KC, Su YC, Sun MF, Huang ST. Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan: A Nationwide Retrospective Population-Based Cohort Study. Front Pharmacol 2018;9:1117. Published 2018 Oct 1. https://doi.org/10.3389/fphar.2018.01117
- Zhong Y, Menon MC, Deng Y, Chen Y, He JC. Recent Advances in Traditional Chinese Medicine for Kidney Disease. Am J Kidney Dis 2015;66(3):513-22. https://doi.org/10.1053/j.ajkd.2015.04.013
- Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions (Version 5.1.0). The Cochrane Collaboration 2011.
- Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151(4):264. https://doi.org/10.7326/0003-4819-151-4-200908180-00135
- The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Copenhagen, Denmark: The Nordic Cochrane Centre, The Cochrane Collaboration 2014.
- Higgins JPT, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928. Published 2011 Oct 18. https://doi.org/10.1136/bmj.d5928
- Cen WX. Clinical Observation on Treatment of 43 Cases of Chronic Glomerulonephritis with Liuwei Dihuang Decoction and Zhuling Decoction. Hunan Journal of Traditional Chinese Medicine 2013;29(11):43-4.
- Chen J, Wang T. Study on the Effect of Compound Zhuling Decoction in the Treatment of Chronic Glomerulonephritis. Journal of China Prescription Drug 2018;16(10):103-4.
- Guan XD, Huang ZH. Analysis of the therapeutic effect of Compound Zhuling Decoction on chronic glomerulonephritis. Chinese Medicine Modern Distance Education of China 2017;15(5):94-5.
- Ma WZ, Wang L, Deng M, Ding XM. Effect of Compound Zhuling Decoction on Urinary Protein Level and Complications in Patients with Chronic Glomerulonephritis. J Med Theor & Prac 2020;33(6):925-7.
- Quan SJ, Lian ML, Xiong MQ, Chen RC. Clinical Study on the Effect of Jiawei Zhuling Decoction on Membranoproliferative Glomerulonephritis. Journal of Traditional Chinese Medicine 2001;42(5):282-4. https://doi.org/10.3321/j.issn:1001-1668.2001.05.019
- Su XH. Observation on Curative Effect of Modified Zhuling Decoction in Treating 30 Cases of Chronic Glomerulonephritis. Chin J of Clinical Rational Drug Use 2010;3(19):58-9.
- Xi YP. Effect of Modified Zhuling Decoction on Chronic Glomerulonephritis. Seek Medical And Ask The Medicine 2013;11(10):162-3.
- Xu WM. Clinical Observation on Treatment of Chronic Glomerulonephritis with Integrative Chinese-Western Medicine. Asia-Pacific Traditional Medicine 2015;11(2):74-5. https://doi.org/10.11954/ytctyy.201502031
- Yang XB. Study on the Effect of Compound Zhuling Decoction in the Treatment of Chronic Glomerulonephritis. China Medical Devices 2017;32(S2):75-6.
- Zhu ZJ. Treatment of 57 Cases of Chronic Glomerulonephritis with Zhuling Decoction. Hunan Journal of Traditional Chinese Medicine 2003;19(2):45.
- Zhang J, Bian L, Ma FZ, Jia Y, Lin P. Efficacy and safety of rituximab therapy for membranous nephropathy: a meta-analysis. Eur Rev Med Pharmacol Sci 2018;22(22):8021-9.
- Cheng J, Zhang W, Zhang XH, He Q, Tao XJ, Chen JH. ACEI/ARB therapy for IgA nephropathy: a meta analysis of randomised controlled trials. Int J Clin Pract 2009;63(6):880-8. https://doi.org/10.1111/j.1742-1241.2009.02038.x
- Su K, Guo L. The progression about clinical and experimental study of polypore umbellate decoction application in chronic kidney. China journal of Chinese medicine 2010;25(148):589-92.
- Wang Z, Feng D. Research progress on the diagnosis and treatment of Zhuling decoction. Chinese medicine modern distance education of china 2017;15(3):143-5.
- Yang B, Xie Y, Guo M, Rosner MH, Yang H, Ronco C. Nephrotoxicity and Chinese Herbal Medicine. Clin J Am Soc Nephrol 2018;13(10):1605-11. https://doi.org/10.2215/CJN.11571017
- Hsieh CF, Huang SL, Chen CL, Chen WT, Chang HC, Yang CC. Non-aristolochic acid prescribed Chinese herbal medicines and the risk of mortality in patients with chronic kidney disease: results from a population-based follow-up study. BMJ Open 2014;4(2):e004033. Published 2014 Feb 21. https://doi.org/10.1136/bmjopen-2013-004033